Scott E. Harpstrite

A blood-based diagnostic test incorporating plasma Aβ42/40 ratio, ApoE proteotype, and age accurately identifies brain amyloid status: findings from a multi cohort validity analysis

Tim West, Kristopher M. Kirmess, Matthew R. Meyer et al. · Molecular Neurodegeneration · 2021 · 220 citations · Full text

Cerenkov Radiation Energy Transfer (CRET) Imaging: A Novel Method for Optical Imaging of PET Isotopes in Biological Systems

Robin S. Dothager, Reece Goiffon, Erin Jackson et al. · PLoS ONE · 2010 · 189 citations · Full text

The PrecivityAD™ test: Accurate and reliable LC-MS/MS assays for quantifying plasma amyloid beta 40 and 42 and apolipoprotein E proteotype for the assessment of brain amyloidosis

Kristopher M. Kirmess, Matthew R. Meyer, Mary S. Holubasch et al. · Clinica Chimica Acta · 2021 · 129 citations · Full text

Assessment of a Plasma Amyloid Probability Score to Estimate Amyloid Positron Emission Tomography Findings Among Adults With Cognitive Impairment

Yan Hu, Kristopher M. Kirmess, Matthew R. Meyer et al. · JAMA Network Open · 2022 · 125 citations · Full text

Gold Nanoparticles Doped with ¹⁹⁹Au Atoms and Their Use for Targeted Cancer Imaging by SPECT

Yongfeng Zhao, Bo Pang, Hannah Luehmann et al. · Advanced Healthcare Materials · 2016 · 79 citations · Full text

Nanoparticles, Nanotherapeutics, Engineering +20